Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Monika, Graeser"'
Autor:
Cornelia Kolberg-Liedtke, Friedrich Feuerhake, Madlen Garke, Matthias Christgen, Ronald Kates, Eva Maria Grischke, Helmut Forstbauer, Michael Braun, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Claudia Schumacher, Sherko Kuemmel, Rachel Wuerstlein, Monika Graeser, Ulrike Nitz, Hans Kreipe, Oleg Gluz, Nadia Harbeck
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-13 (2022)
Abstract Background Higher density of stromal tumor-infiltrating lymphocytes (sTILs) at baseline has been associated with increased rates of pathological complete response (pCR) after neoadjuvant chemotherapy (NACT) in triple-negative breast cancer (
Externí odkaz:
https://doaj.org/article/8e767ca38fb44eb2b85c5566cfa49c03
Autor:
Matthias Christgen, Leonie Donata Kandt, Wiebke Antonopoulos, Stephan Bartels, Mieke R VanBockstal, Martin Bredt, Maria Jose Brito, Henriette Christgen, Cecile Colpaert, Bálint Cserni, Gábor Cserni, Maximilian E Daemmrich, Raihanatou Danebrock, Franceska Dedeurwaerdere, Carolien HM vanDeurzen, Ramona Erber, Christine Fathke, Henning Feist, Maryse Fiche, Claudia Aura Gonzalez, Natalie D terHoeve, Loes Kooreman, Till Krech, Glen Kristiansen, Janina Kulka, Florian Laenger, Marcel Lafos, Ulrich Lehmann, Maria Dolores Martin‐Martinez, Sophie Mueller, Enrico Pelz, Mieke Raap, Alberto Ravarino, Tanja Reineke‐Plaass, Nora Schaumann, Anne‐Marie Schelfhout, Maxim DeSchepper, Jerome Schlue, Koen Van de Vijver, Wim Waelput, Axel Wellmann, Monika Graeser, Oleg Gluz, Sherko Kuemmel, Ulrike Nitz, Nadia Harbeck, Christine Desmedt, Giuseppe Floris, Patrick WB Derksen, Paul J vanDiest, Anne Vincent‐Salomon, Hans Kreipe
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 8, Iss 2, Pp 191-205 (2022)
Abstract Invasive lobular breast carcinoma (ILC) is the second most common breast carcinoma (BC) subtype and is mainly driven by loss of E‐cadherin expression. Correct classification of BC as ILC is important for patient treatment. This study asses
Externí odkaz:
https://doaj.org/article/315199064a574f7f8e979a65ce71d4f6
Autor:
Isabel Grote, Stephan Bartels, Leonie Kandt, Laura Bollmann, Henriette Christgen, Malte Gronewold, Mieke Raap, Ulrich Lehmann, Oleg Gluz, Ulrike Nitz, Sherko Kuemmel, Christine zuEulenburg, Michael Braun, Bahriye Aktas, Eva‐Maria Grischke, Claudia Schumacher, Kerstin Luedtke‐Heckenkamp, Ronald Kates, Rachel Wuerstlein, Monika Graeser, Nadia Harbeck, Matthias Christgen, Hans Kreipe
Publikováno v:
Cancer Medicine, Vol 10, Iss 23, Pp 8581-8594 (2021)
Abstract Background Whereas the genomic landscape of endocrine‐resistant breast cancer has been intensely characterized in previously treated cases with local or distant recurrence, comparably little is known about genomic alterations conveying pri
Externí odkaz:
https://doaj.org/article/2c544d649b024c5bbd721b91d7f7c740
Autor:
Monika Graeser, Nadia Harbeck, Oleg Gluz, Rachel Würstlein, Christine zu Eulenburg, Claudia Schumacher, Eva-Maria Grischke, Helmut Forstbauer, Moritz Dimpfl, Michael Braun, Matthias Christgen, Hans Heinrich Kreipe, Jochem Potenberg, Raquel von Schumann, Bahriye Aktas, Cornelia Kolberg-Liedtke, Sherko Kümmel, Ulrike Nitz
Publikováno v:
Breast, Vol 59, Iss , Pp 58-66 (2021)
Objective: We assessed the value of breast ultrasound (US) performed at week 3 and 6 and at the end (EOT) of neoadjuvant therapy (NAT) for prediction of pathologic complete response (pCR, ypT0/is ypN0) in patients with HR+/HER2+, HR-/HER2-or HR-/HER2
Externí odkaz:
https://doaj.org/article/5a1f7a16eaed4e7f94e246831a6ca2c9
Autor:
Monika Graeser, Simone Schrading, Oleg Gluz, Kevin Strobel, Christopher Herzog, Lale Umutlu, Alex Frydrychowicz, Dorothea Rjosk-Dendorfer, Rachel Würstlein, Ralph Culemann, Christine Eulenburg, Jascha Adams, Henrik Nitzsche, Anna Prange, Sherko Kümmel, Eva-Maria Grischke, Helmut Forstbauer, Michael Braun, Jochem Potenberg, Raquel von Schumann, Bahriye Aktas, Cornelia Kolberg-Liedtke, Nadia Harbeck, Christiane K. Kuhl, Ulrike Nitz
Publikováno v:
Breast Cancer Research, Vol 23, Iss 1, Pp 1-13 (2021)
Abstract Background Prediction of histological tumor size by post-neoadjuvant therapy (NAT) ultrasound and magnetic resonance imaging (MRI) was evaluated in different breast cancer subtypes. Methods Imaging was performed after 12-week NAT in patients
Externí odkaz:
https://doaj.org/article/2b0e3db5c69b4345bac7835ff7078f9c
Autor:
Eva-Maria Grischke, Nadia Harbeck, Michael Braun, Katarzyna Jozwiak, Michael Hauptmann, Claudia Schumacher, Monika Graeser, Friedrich Feuerhake, Oleg Gluz, Valery Volk, Matthias Christgen, Sherko Kuemmel, Helmut Forstbauer, Mathias Warm, John Hackmann, Christoph Uleer, Bahriye Aktas, Cornelia Kolberg-Liedtke, Ronald Kates, Rachel Wuerstlein, Ulrike Nitz, Hans Heinrich Kreipe
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background The association of early changes in the immune infiltrate during neoadjuvant chemotherapy (NACT) with pathological complete response (pCR) in triple-negative breast cancer (TNBC) remains unexplored.Methods Multiplexed immunohistochemistry
Externí odkaz:
https://doaj.org/article/2aeee82f7d4040a2a3560c86347de744
Autor:
Oleg Gluz, Monika Graeser
Publikováno v:
Current Oncology Reports. 25:491-500
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::662ff2f3851338d0fbb24e9171a086e7
https://doi.org/10.1007/s11912-023-01377-6
https://doi.org/10.1007/s11912-023-01377-6
Autor:
Isabel Grote, Stephan Bartels, Henriette Christgen, Martin Radner, Malte Gronewold, Leonie Kandt, Mieke Raap, Ulrich Lehmann, Oleg Gluz, Monika Graeser, Sherko Kuemmel, Ulrike Nitz, Nadia Harbeck, Hans Kreipe, Matthias Christgen
Publikováno v:
Modern Pathology. 35:1804-1811
Invasive lobular breast cancer (ILC) is a special breast cancer (BC) subtype and is mostly hormone receptor (HR)-positive and ERBB2 non-amplified. Endocrine therapy restrains tumor proliferation and is the mainstay of lobular BC treatment. Mutation o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f839ae3742e3a824d98f56946ccf98ff
https://doi.org/10.1038/s41379-022-01130-7
https://doi.org/10.1038/s41379-022-01130-7
Autor:
Sherko Kuemmel, Oleg Gluz, Mattea Reinisch, Athina Kostara, Iris Scheffen, Monika Graeser, Kerstin Luedtke-Heckenkamp, Andreas Hartkopf, Felix Hilpert, Angela Kentsch, Carsten Ziske, Reinhard Depenbusch, Michael Braun, Jens Blohmer, Christine zu Eulenburg, Matthias Christgen, Stephan Bartels, Hans Kreipe, Enrico Pelz, Peter Schmid, Nadia Harbeck
Publikováno v:
Cancer Research. 82:P2-13
Background: De-escalating strategies seem promising inHER2-positive early breast cancer (EBC) and chemo-free regimens are thus of keyinterest. Recent data have underlined the role of tumor immunogenicity inresponse to de-escalated neoadjuvant anti-HE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9c55b0b73a0dc08cdb1deaa3ffae875
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-03
https://doi.org/10.1158/1538-7445.sabcs21-p2-13-03
Autor:
Nadia Harbeck, Ulrike Nitz, Hans Heinrich Kreipe, Friedrich Feuerhake, Cornelia Kolberg-Liedtke, Hua Ni, Ronald Kates, Christine zu Eulenburg, Enrico Pelz, Hans Holger Fischer, Andrea Stefek, Toralf Reimer, Helmut Forstbauer, Claudia Schumacher, Katja Krauss, Rachel Wuerstlein, Jochem Potenberg, Michael Braun, Doris Augustin, Eva-Maria Grischke, Sherko Kuemmel, Jenci Palatty, Matthias Christgen, Daniel Ulbrich-Gebauer, Claudia Biehl, Oleg Gluz, Monika Graeser
Supplementary Table 1 lists genes comprising the RNA expression signatures measured with the BC360 panel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e60314eda6d7136a291f05f0aa7b39c
https://doi.org/10.1158/1078-0432.22490620.v1
https://doi.org/10.1158/1078-0432.22490620.v1
